Employers at an ‘inflection point’ as health costs near double-digit increases
Source: HR Dive ↗
Healthcare costs for large U.S. employers are projected to surge by nearly 10% in 2026, according to the Business Group on Health’s (BGH) latest annual survey, which gathered responses from 127 employers covering 8.7 million individuals. The year‑over‑year increase of 8.8% recorded for 2025 was the highest ever reported by BGG members, marking the third consecutive year that actual expenses exceeded employers’ own forecasts. Disease categories such as cancer, musculoskeletal and cardiovascular conditions, together with rising prices for hospitals, outpatient facilities and pharmaceuticals, were identified as the primary drivers of the cost escalation. Pharmacy spending alone is expected to climb 12% by 2027, even as many employers have already locked in their 2026 benefits budgets, leaving them unable to implement substantial cost‑cutting measures until at least 2028.
In response to the mounting financial pressure, employers are intensifying scrutiny of vendors and third‑party partnerships. Ninety‑five percent of survey participants have issued requests for proposals, and 58% plan to replace underperforming vendors or eliminate low‑utilization programs, while 83% are expanding performance guarantees with health partners. A notable shift is occurring toward more transparent or “new‑generation” pharmacy benefit manager (PBM) arrangements, with roughly one‑third of respondents expecting such contracts in place by 2027 and an additional 47% considering them for future years; employers anticipate a 12‑ to 18‑month transition period to ensure due diligence. Moreover, 82% already employ a centers‑of‑excellence (COE) model for certain care pathways, and 12% are planning to add or explore COE options, reflecting broader movement toward value‑based solutions, high‑performance networks, and accountable care organizations.
Coverage of GLP‑1 drugs, particularly for weight management, is being sharply reduced as employers grapple with affordability and the drugs’ expanding direct‑to‑consumer market. No employer in the survey intends to add weight‑loss GLP‑1 coverage for 2027, and 14% plan to drop it altogether, while 60% maintaining the benefit intend to impose stricter utilization controls such as clinical eligibility verification or mandatory participation in weight‑management programs. This retrenchment mirrors findings from the SHRM Employee Benefits Survey, which noted broader coverage for GLP‑1s in diabetes treatment but limited support for weight‑loss indications. Employers are weighing whether to preserve overall plan viability while still offering anti‑obesity options, including alternative medications, lifestyle interventions, nutrition programs, or bariatric surgery, as the landscape of employer‑sponsored health benefits continues to evolve under unprecedented cost pressures.
⚡ Effects Interpreter
🌍World Economylow impact
What this means for you
- ▶Export-heavy economies might see demand wobble as buyers wait and watch.
- ▶Global boardrooms tend to take notice when this kind of news surfaces.
🏙️Local Economylow impact
What this means for you
- ▶Household budgets might notice a small ripple before long.
- ▶Your weekly shop might get a touch dearer, or cheaper, over time.
🏦Rates & Bankslow impact
What this means for you
- ▶Your loan or mortgage rate is more likely to drift than to lurch here.
- ▶Interest rates and mortgage bills are unlikely to jump straight away from this alone.
❤️Healthmedium impact
What this means for you
- ▶Good information, shared kindly, can settle a lot of nerves.
- ▶Staying calm and informed tends to help more than worrying alone.
💷Wealthlow impact
What this means for you
- ▶Days lost to illness can subtly dent household income.
- ▶Healthcare or insurance costs may edge up if treatments become common.
🏠Housinglow impact
What this means for you
- ▶House prices and rents are unlikely to shift the moment this news breaks.
- ▶Rental yields in the area might shift only slightly, if at all, from this.
🌍 Effects for your country
The U.S.'s central bank rate currently stands at 3.75%, so a global rates move like this could feed through to local borrowing costs. The U.S.'s economy is growing at 2.3% with inflation at 3.2%, the backdrop this story's effects play out against locally. Housing-market effects like this are usually felt most where mortgage rates track the U.S.'s own central bank rate closely. With the U.S.'s unemployment at 4.4%, personal-finance effects like this land on a labour market that is currently fairly stable. Health-system effects are harder to localise from economic indicators alone — the real impact in the U.S. depends more on local healthcare capacity than the figures above.
The UK's central bank rate currently stands at 3.75%, so a global rates move like this could feed through to local borrowing costs. The UK's economy is growing at 0.8% with inflation at 3.2%, the backdrop this story's effects play out against locally. Housing-market effects like this are usually felt most where mortgage rates track the UK's own central bank rate closely. With the UK's unemployment at 5.6%, personal-finance effects like this land on a labour market that is currently fairly stable. Health-system effects are harder to localise from economic indicators alone — the real impact in the UK depends more on local healthcare capacity than the figures above.
France's central bank rate currently stands at 2%, so a global rates move like this could feed through to local borrowing costs. France's economy is growing at 0.9% with inflation at 1.8%, the backdrop this story's effects play out against locally. Housing-market effects like this are usually felt most where mortgage rates track France's own central bank rate closely. With France's unemployment at 7.9%, personal-finance effects like this land on a labour market that is already under strain. Health-system effects are harder to localise from economic indicators alone — the real impact in France depends more on local healthcare capacity than the figures above.
Romania's central bank rate currently stands at 6.5%, so a global rates move like this could feed through to local borrowing costs. Romania's economy is growing at 0.7% with inflation at 7.8%, the backdrop this story's effects play out against locally. Housing-market effects like this are usually felt most where mortgage rates track Romania's own central bank rate closely. With Romania's unemployment at 6%, personal-finance effects like this land on a labour market that is currently fairly stable. Health-system effects are harder to localise from economic indicators alone — the real impact in Romania depends more on local healthcare capacity than the figures above.
The UAE's central bank rate currently stands at 3.65%, so a global rates move like this could feed through to local borrowing costs. The UAE's economy is growing at 3.1% with inflation at 2.5%, the backdrop this story's effects play out against locally. Housing-market effects like this are usually felt most where mortgage rates track the UAE's own central bank rate closely. Health-system effects are harder to localise from economic indicators alone — the real impact in the UAE depends more on local healthcare capacity than the figures above.